X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Cadila Healthcare Fact Sheet, Cadila Healthcare Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cadila Healthcare Fact Sheet   (CADIL)

Here is the latest financial fact sheet of Cadila Healthcare. For more details, see the Cadila Healthcare quarterly results and Cadila Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.

CADILA HEALTHCARE Price History

Price Rs 252.5
Mkt Cap Rs m 258,494
Vol '000 465.8
P/E X 13.2
P/CF X 11.2
EPS (TTM) Rs 19.2
% ch % 0.6
No. of shares m 1,023.74
% ch week % -3.0
% ch 1-mth % -23.6
% ch 12-mth % -26.5
52 week H/L Rs 432.4/241.6
(As on May 23, 2019 11:17:00 AM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CADILA HEALTHCARE Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
CADILA HEALTHCARE EQUITY SHARE DATA
High Rs1,0791,763454460558 
Low Rs631872305305362 
Sales per share (Unadj.) Rs352.8422.592.191.6116.3 
Earnings per share (Unadj.) Rs39.256.219.214.817.9 
Diluted earnings per shareRs7.811.219.214.817.9 
Cash flow per share (Unadj.) Rs49.170.222.018.523.1 
Dividends per share (Unadj.) Rs9.0012.003.203.203.50 
Adj. dividends per shareRs1.802.403.203.203.50 
Dividend yield (eoy) %1.10.90.80.80.8 
Book value per share (Unadj.) Rs168.0220.855.768.085.4 
Adj. book value per shareRs33.644.255.768.085.4 
Shares outstanding (eoy) m204.75204.751,023.741,023.741,023.74 
Bonus/Rights/Conversions  --FV5:1-- 
Price / Sales ratio x2.43.14.14.24.0 
Avg P/E ratio x21.823.419.825.825.7 
P/CF ratio (eoy) x17.418.817.220.719.9 
Price / Book Value ratio x5.16.06.85.65.4 
Dividend payout %22.921.416.721.619.6 
Avg Mkt Cap Rs m175,061269,758388,458391,581470,664 
No. of employees `00012.213.215.416.911.8 
Total wages/salary Rs m10,71112,08512,61615,19818,545 
Avg. sales/employee Rs Th5,908.26,564.06,105.05,563.010,072.7 
Avg. wages/employee Rs Th876.0916.9817.0901.71,569.1 
Avg. net profit/employee Rs Th657.2873.01,272.1901.51,547.7 
CADILA HEALTHCARE INCOME DATA
Net Sales Rs m72,24086,51394,26893,765119,049 
Other income Rs m5075541,1561,2841,132 
Total revenues Rs m72,74787,06795,42495,049120,181 
Gross profit Rs m12,00117,59923,30519,04428,475 
Depreciation Rs m2,0122,8732,9213,7335,388 
Interest Rs m902679528446911 
Profit before tax Rs m9,59414,60121,01216,14923,308 
Minority Interest Rs m-326-397430338628 
Prior Period Items Rs m26542000 
Extraordinary Inc (Exp) Rs m-172-104-25-30 
Tax Rs m1,3252,6361,7741,2895,644 
Profit after tax Rs m8,03611,50619,64315,19518,292 
Gross profit margin %16.620.324.720.323.9 
Effective tax rate %13.818.18.48.024.2 
Net profit margin %11.113.320.816.215.4 
CADILA HEALTHCARE BALANCE SHEET DATA
Current assets Rs m34,37940,88742,80460,22382,005 
Current liabilities Rs m28,14029,92134,61053,05860,720 
Net working cap to sales %8.612.78.77.617.9 
Current ratio x1.21.41.21.11.4 
Inventory Days Days6960527073 
Debtors Days Days5769688998 
Net fixed assets Rs m40,15340,52646,98772,98483,703 
Share capital Rs m1,0241,0241,0241,0241,024 
"Free" reserves Rs m27,84544,18455,96868,57686,421 
Net worth Rs m34,39045,20856,99269,60087,445 
Long term debt Rs m13,62211,5048,96424,68425,551 
Total assets Rs m79,86591,342105,506152,207180,653 
Interest coverage x11.622.540.837.226.6 
Debt to equity ratio x0.40.30.20.40.3 
Sales to assets ratio x0.90.90.90.60.7 
Return on assets %11.213.319.110.310.6 
Return on equity %23.425.534.521.820.9 
Return on capital %21.426.133.318.022.0 
Exports to sales %27.732.547.200 
Imports to sales %5.86.26.200 
Exports (fob) Rs m20,03828,08044,53700 
Imports (cif) Rs m4,2105,3915,83800 
Fx inflow Rs m20,61329,66644,88121,28042,683 
Fx outflow Rs m6,8648,0939,06910,87411,242 
Net fx Rs m13,74921,57335,81210,40631,441 
CADILA HEALTHCARE CASH FLOW
From Operations Rs m 9,028 9,936 18,935 13,117 9,193 
From Investments Rs m -4,380 -4,647 -8,635 -28,719 -9,737 
From Financial Activity Rs m -5,287 -3,511 -9,348 23,158 515 
Net Cashflow Rs m -639 1,778 991 7,556 -29 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 8.3%
FIIs 5.9%
ADR/GDR 0.0%
Free float 11.0%
Shareholders 44,069
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Zydus Tower, Satellite Cross Roads, Ahmedabad - 380 015
E-MAIL upen.shah@zyduscadila.com WEB www.zyduscadila.com
TELEPHONE (079) 2686 8326 FAX (079) 2686 2365
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Sharepro Serv.,416-420, Devnandan Mall, Ellisbridge, Ahmedabad-09
AUDITOR Mukesh M. Shah & Co.
CHM: Pankaj R. Patel (MD) COMP SEC: Upen H. Shah YEAR OF INC: 1995 BSE CODE: 532321 FV (Rs): 5 DIV YIELD (%): 1.4

Read: CADILA HEALTHCARE 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   NOVARTIS  J.B.CHEMICALS  ELDER PHARMA  PLETHICO PHARMA  IPCA LABS  

Compare CADILA HEALTHCARE With:   NOVARTIS  J.B.CHEMICALS  ELDER PHARMA  PLETHICO PHARMA  IPCA LABS  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex and Nifty Open at Record Highs; Modi Takes Early Lead(09:30 am)

Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.8% while the Hang Seng is down 1.2%.

Views on news

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - DR. REDDYS LAB COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS